-
-
-
-
-
-
-
Disc Medicine plans to submit bitopertin NDA in October 2025
-
-
-
-
-
-
-
Autolus receives European approval for CAR T therapy AUCATZYL
-
-
-
-
-
-
-
Nuvalent starts phase 3 trial of neladalkib for lung cancer patients
-
-
-
-
-
-
-
European Commission approves SpringWorks' EZMEKLY for rare tumor condition
-
-
-
-
-
-
-
Eledon to present kidney transplant drug data at medical congress
-
-
-
-
-
-
-
Johnson & Johnson gets FDA priority review for bladder cancer treatment
-
-
-
-
-
-
-
Wallbridge begins phase 2 drilling at Martiniere gold project
-
71,246 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving FDA reports.